Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 7/2019

Open Access 01-07-2019 | Breast Cancer | Original Article – Clinical Oncology

Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany

Authors: Vinzenz Voelkel, Teresa Draeger, Catharina G. M. Groothuis-Oudshoorn, Linda de Munck, Tom Hueting, Michael Gerken, Monika Klinkhammer-Schalke, Miha Lavric, Sabine Siesling

Published in: Journal of Cancer Research and Clinical Oncology | Issue 7/2019

Login to get access

Abstract

Purpose

Follow-up after breast cancer treatment aims for an early detection of locoregional breast cancer recurrences (LRR) to improve the patients’ outcome. By estimating individual’s 5-year recurrence-risks, the Dutch INFLUENCE-nomogram can assist health professionals and patients in developing personalized risk-based follow-up pathways. The objective of this study is to validate the prediction tool on non-Dutch patients.

Material and methods

Data for this external validation derive from a large clinical cancer registry in southern Germany, covering a population of 1.1 million. Patients with curative resection of early-stage breast cancer, diagnosed between 2000 and 2012, were included in the analysis (n = 6520). For each of them, an individual LRR-risk was estimated by the INFLUENCE-nomogram. Its predictive ability was tested by comparing estimated and observed LRR-probabilities using the Hosmer–Lemeshow goodness-of-fit test and C-statistics.

Results

In the German validation-cohort, 2.8% of the patients developed an LRR within 5 years after primary surgery (n = 184). While the INFLUENCE-nomogram generally underestimates the actual LRR-risk of the German patients (p < 0.001), its discriminative ability is comparable to the one observed in the original Dutch modeling-cohort (C-statistic German validation-cohort: 0.73, CI 0.69–0.77 vs. C-statistic Dutch modeling-cohort: 0.71, CI 0.69–0.73). Similar results were obtained in most of the subgroup analyses stratified by age, type of surgery and intrinsic biological subtypes.

Conclusion

The outcomes of this external validation underline the generalizability of the INFLUENCE-nomogram beyond the Dutch population. The model performance could be enhanced in future by incorporating additional risk factors for LRR.
Literature
go back to reference Bayerisches Landesamt für Statistik und Datenverarbeitung (2014) Zensus 2011: Daten zur Altersstruktur der Bevölkerung für den Regierungsbezirk Oberpfalz, München Bayerisches Landesamt für Statistik und Datenverarbeitung (2014) Zensus 2011: Daten zur Altersstruktur der Bevölkerung für den Regierungsbezirk Oberpfalz, München
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRefPubMed
go back to reference Deutsches Institut für Medizinische Dokumentation und Information (2017) ICD-10-GM version 2017 systematisches verzeichnis internationale statistische klassifikation der krankheiten und verwandter gesundheitsprobleme, 10. Revision—German Modification. https://www.icd-code.de/ops/code/OPS.html. Accessed 19 Nov 2017 Deutsches Institut für Medizinische Dokumentation und Information (2017) ICD-10-GM version 2017 systematisches verzeichnis internationale statistische klassifikation der krankheiten und verwandter gesundheitsprobleme, 10. Revision—German Modification. https://​www.​icd-code.​de/​ops/​code/​OPS.​html. Accessed 19 Nov 2017
go back to reference Hermanek P, Wittekind C (1994) Residual tumor (R) classification and prognosis. Semin Surg Oncol 10(1):12–20CrossRefPubMed Hermanek P, Wittekind C (1994) Residual tumor (R) classification and prognosis. Semin Surg Oncol 10(1):12–20CrossRefPubMed
go back to reference Hosmer DW Jr, Lemeshow S, Sturdivant RX (2013) Applied Logistic Regression. Wiley, HobokenCrossRef Hosmer DW Jr, Lemeshow S, Sturdivant RX (2013) Applied Logistic Regression. Wiley, HobokenCrossRef
go back to reference Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346CrossRefPubMed Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346CrossRefPubMed
go back to reference Stewart BW, Wild CP (2014) World Cancer Report 2014. Online-Ausg. EBL-Schweitzer, International Agency for Research on Cancer/World Health Organization, Lyon Stewart BW, Wild CP (2014) World Cancer Report 2014. Online-Ausg. EBL-Schweitzer, International Agency for Research on Cancer/World Health Organization, Lyon
go back to reference Steyerberg EW (2009) Clinical prediction models: a practical approach to development, validation, and updating. statistics for biology and health. Springer, New York Steyerberg EW (2009) Clinical prediction models: a practical approach to development, validation, and updating. statistics for biology and health. Springer, New York
Metadata
Title
Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany
Authors
Vinzenz Voelkel
Teresa Draeger
Catharina G. M. Groothuis-Oudshoorn
Linda de Munck
Tom Hueting
Michael Gerken
Monika Klinkhammer-Schalke
Miha Lavric
Sabine Siesling
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 7/2019
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-02904-4

Other articles of this Issue 7/2019

Journal of Cancer Research and Clinical Oncology 7/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.